#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Genomic analysis of Shiga toxin-producing Escherichia coli from patients and asymptomatic food handlers in Japan


Authors: Hiroaki Baba aff001;  Hajime Kanamori aff001;  Hayami Kudo aff002;  Yasutoshi Kuroki aff002;  Seiya Higashi aff002;  Kentaro Oka aff002;  Motomichi Takahashi aff002;  Makiko Yoshida aff001;  Kengo Oshima aff001;  Tetsuji Aoyagi aff001;  Koichi Tokuda aff001;  Mitsuo Kaku aff001
Authors place of work: Department of Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan aff001;  Miyarisan Pharmaceutical Co., Ltd., Saitama-shi, Saitama, Japan aff002
Published in the journal: PLoS ONE 14(11)
Category: Research Article
doi: https://doi.org/10.1371/journal.pone.0225340

Summary

Shiga toxin-producing Escherichia coli (STEC) can cause severe gastrointestinal disease and colonization among food handlers. In Japan, STEC infection is a notifiable disease, and food handlers are required to undergo routine stool examination for STEC. However, the molecular epidemiology of STEC is not entirely known. We investigated the genomic characteristics of STEC from patients and asymptomatic food handlers in Miyagi Prefecture, Japan. Whole-genome sequencing (WGS) was performed on 65 STEC isolates obtained from 38 patients and 27 food handlers by public health surveillance in Miyagi Prefecture between April 2016 and March 2017. Isolates of O157:H7 ST11 and O26:H11 ST21 were predominant (n = 19, 29%, respectively). Non-O157 isolates accounted for 69% (n = 45) of all isolates. Among 48 isolates with serotypes found in the patients (serotype O157:H7 and 5 non-O157 serotypes, O26:H11, O103:H2, O103:H8, O121:H19 and O145:H28), adhesion genes eae, tir, and espB, and type III secretion system genes espA, espJ, nleA, nleB, and nleC were detected in 41 to 47 isolates (85–98%), whereas isolates with other serotypes found only in food handlers were negative for all of these genes. Non-O157 isolates were especially prevalent among patients younger than 5 years old. Shiga-toxin gene stx1a, adhesion gene efa1, secretion system genes espF and cif, and fimbrial gene lpfA were significantly more frequent among non-O157 isolates from patients than among O157 isolates from patients. The most prevalent resistance genes among our STEC isolates were aminoglycoside resistance genes, followed by sulfamethoxazole/trimethoprim resistance genes. WGS revealed that 20 isolates were divided into 9 indistinguishable core genomes (<5 SNPs), demonstrating clonal expansion of these STEC strains in our region, including an O26:H11 strain with stx1a+stx2a. Non-O157 STEC with multiple virulence genes were prevalent among both patients and food handlers in our region of Japan, highlighting the importance of monitoring the genomic characteristics of STEC.

Keywords:

Phylogenetic analysis – Virulence factors – Secretion systems – Age groups – Antimicrobial resistance – Escherichia coli – Japan – Hemolytic-uremic syndrome

Introduction

Shiga toxin-producing Escherichia coli (STEC) cause various gastrointestinal diseases in humans, including life-threatening hemolytic uremic syndrome (HUS) [1]. Although O157:H7 is the predominant pathogenic serotype, severe infections caused by non-O157 serogroups are increasingly reported worldwide [2]. STEC transmission occurs through intake of contaminated food or via person-to-person spread, with large-scale outbreaks having been reported [1]. In Japan, food safety control measures and a STEC surveillance system were instituted after a massive STEC epidemic occurred in Sakai city in 1996, and STEC infection became a notifiable disease [3]. To prevent the spread of infection via food, the Japanese Ministry of Health, Labor and Welfare requires food handlers to undergo routine stool examination for various infectious pathogens, including STEC, and asymptomatic STEC carriers are legally restricted from working as food handlers [4]. Despite these efforts, approximately 4,000 cases of STEC infection are still reported annually in Japan [3].

Shiga toxin (Stx) is the most important STEC virulence factor. Stx has 2 subtypes with variants, which are Stx1 (stx1a, stx1c, and stx1d) and Stx2 (stx2a, stx2b, stx2c, stx2d, stx2e, stx2f, and stx2g) [5]. In addition, highly pathogenic STEC possess other virulence factors that include adhesins, other toxins, and protein secretion systems [1]. Detection of genes encoding these virulence factors in STEC strains could provide useful information about risk factors that may contribute to human disease. In recent years, there has been a worldwide increase of reports about antimicrobial resistance (AMR) among STEC strains [6]. In STEC carriers taking antibiotics, resistant STEC strains may have a selection advantage over other intestinal bacteria. Because of the public health implications of STEC infection, a comprehensive investigation of virulence and AMR factors is required to assess the potential pathogenicity and antibiotic resistance of STEC isolates from patients and asymptomatic food handlers. Some European authors have investigated the molecular characteristics of STEC isolates [7, 8], but no molecular epidemiological studies have been done to assess the relationship between STEC isolates from patients and food handlers. In the present study, we investigated molecular epidemiology of STEC infection in Miyagi Prefecture, Japan, and performed whole-genome sequencing (WGS) to characterize the genomic features of STEC isolates from patients and asymptomatic food handlers including virulence factors and AMR genes.

Material and methods

Bacterial strains and clinical data

From April 2016 to March 2017, we collected all 65 epidemiologically unlinked STEC isolates detected through public health surveillance for infectious diseases in Miyagi Prefecture, which is located in central northeastern Japan and has a population of about 2.3 million. Thirty-eight isolates were obtained from fecal samples of hospital patients and 27 isolates were detected by routine stool examination of asymptomatic food handlers. Isolation of STEC from stool samples was done with sorbitol-MacConkey agar containing cefixime and tellurite in addition to conventional E. coli isolation agar (e.g., triple sugar iron agar and lysine-indole-motility medium). A latex agglutination test (VTEC-RPLA, Denka Seiken, Japan) and PCR with the EVT-1&2 and EVS-1&2 primers (TaKaRa Biomedicals, Tokyo, Japan) were used to detect Stx and Stx genes, respectively.

Patient data (e.g., age, sex, and clinical manifestation) were also collected through STEC public health surveillance. Patients were divided into four age groups: infants and small children (0–4 y), older children and adolescents (5–19 y), adults (20–64 y), and older people (>65 y) [9]. The age-specific incidence of STEC infections per 100,000 population by age group was calculated using Miyagi Prefecture population data obtained from the National Institute of Population and Social Security Research website (http://www.ipss.go.jp/). This study was approved by the institutional review board of Tohoku University Graduate School of Medicine (IRB no. 2018-1-368).

Whole-genome sequencing

Bacterial DNA from the 65 isolates was extracted as described previously [10], and a DNA library was prepared from each sample with a NEBNext Ultra DNA Library Prep Kit for Illumina (New England Biolabs, Ipswich, MA, USA) according to the manufacturer’s instructions. Then WGS was performed using a MiSeq (Illumina, San Diego, CA, USA) to generate paired-end 300-bp reads, resulting in an average of 5,556,073 read pairs per isolate. All samples showed a minimum average 30-fold coverage. The passing filter ranged from 90.88 to 96.74% (mean, 93.19%), and the average Q30 ranged from 78.30 to 87.21% (mean, 83.50%). All of the sequence data reported here have been deposited in DDBJ/EMBL/Genbank Sequence Read Archive (SRA) under accession numbers DRX149942 to DRX150006.

Genetic analysis

Sequence reads were trimmed of adaptors and filtered to remove reads shorter than 36 bp using Trimmomatic [11], followed by assembly using Platanus assembler v 1.2.4. [12]. Specific genes and alleles were identified with the bioinformatic pipeline of the Center for Genomic Epidemiology (http://www.genomicepidemiology.org), using the default setting of a 90% ID threshold and 60% minimum gene length overlap, except where otherwise stated. Specifically, SerotypeFinder 1.1 [13] was used to identify serogenotypes, MLST Finder 2.0 [14] was employed for multilocus sequence typing (MLST), VirulenceFinder 1.5 [15] was used for virulence genes, and ResFinder 3.0 [16] was employed for acquired AMR genes. We also searched for the major adhesin gene saa, which cannot be detected by VirulenceFinder, using BLAST (http://blast.ncbi.nlm.nih.gov).

A non-recombinogenic core genome single-nucleotide polymorphism (SNP)-based phylogeny was generated with Parsnp v 1.2 (https://harvest.readthedocs.io/en/latest/content/parsnp/quickstart.html#advanced-usage) [17] using the 65 STEC isolates and the following 6 reference genomes: STEC O157:H7 Sakai (GenBank accession numbers: BA000007), STEC O157:H7 strain EDL933 (AE005174), STEC O157:H7 strain EC4115 (CP001164), STEC O157:H7 strain TW14359 (CP001368), STEC O26:H11 strain 11368 (AP010953), and STEC O103:H2 strain 12009 (AP010958). Differences in the number of SNPs between STEC strains were calculated by Parsnp. Clonal STEC strains were defined as isolates with less than 5 SNPs [18]. A phylogenetic tree with 1000 boostrap replicates was constructed by using the randomized accelerated maximum likelihood (RAxML) program v 8.2.12 (https://cme.h-its.org/exelixis/web/software/raxml/index.html) [19], and it was visualized with FigTree (http://tree.bio.ed.ac.uk/software/figtree/).

Statistical analysis

Fisher’s exact test and the two-sample t-test were used for analysis of categorical variables and continuous variables, respectively. In all analyses, P<0.05 was considered statistically significant.

Results

Serogenotyping and MLST

Among the 65 STEC isolates, serogenotyping and MLST revealed 18 different serogroups and 20 different sequence types (Fig 1). Seven sequence types had already been reported as STECs causing human disease according to Enterobase (http://enterobase.warwick.ac.uk), while the other 13 sequence types, including O103:H8 ST2836, are new as STEC strains. An O-group was not detected in the one OUT (O-serotype untypable) isolate by SerotypeFinder. In this isolate, no O-processing genes (wzx, wzy, wzm, wzt) were detected by BLAST. It is possible that this isolate could be assigned to serogroups O14 or O57 since O-processing genes for these serogroups have not been found in their genomes [20], or it could represent a new serogroup.

Frequency of O/H serotypes and sequence types (STs) among Shiga-toxin producing <i>Escherichia coli</i> (STEC) isolates.
Fig. 1. Frequency of O/H serotypes and sequence types (STs) among Shiga-toxin producing Escherichia coli (STEC) isolates.
Red and blue bars represent the number of isolates from patients and asymptomatic food handlers, respectively. *New STEC STs. aMajor serotypes: serotypes found in patients in this study. bMinor serotypes: serotypes only found in food handlers in this study. cOUT: O-serotype untypable.

Non-O157 isolates accounted for 69% (n = 45) of all isolates. O157 isolates were significantly more frequent among the patients than the food handlers (19/38 isolates from patients versus 1/27 isolates from food handlers, P<0.001), whereas non-O157 isolates were significantly more frequent among the food handlers. Among isolates from the patients, the predominant serotype was O157:H7 (n = 19, 50%) followed by O26:H11 (n = 14, 37%), while O26:H11 was predominant (n = 6, 22%) among isolates from the food handlers, followed by O103:H2, O181:H49, O55:H12, O76:H19, O91:H14, and O8:H19 (n = 2, 7.4%, respectively). Isolates from patients belonged to the following 6 serotypes (O157:H7 and 5 non-O157 serotypes, which were O26:H11, O103:H2, O103:H8, O121:H19, and O145:H28) (hereinafter called “major serotypes”), while the remaining 12 serotypes were only found in the food handlers (hereinafter called “minor -serotypes”) (Fig 1). Isolates with the same serotype generally belonged to the same sequence type, except that O157:H7 isolates belonged to ST11 and ST2966, O26:H11 isolates belonged to ST21 and ST1705, and O8:H19 isolates belonged to ST88 and ST2385. There was only one SNP difference between ST11 and ST2966 in purA, as well as between ST21 and ST1705 in gyrA, suggesting a close relation between these sequence types.

Clinical characteristics of patients and food handlers

The majority of the patients (28/38, 74%) had bloody diarrhea and 1 patient (2.6%) developed HUS, while the symptoms of the remaining 10 patients (36%) were unknown. The patients were aged between 11 months and 85 years (median: 17.5 years), whereas the food handlers were aged from 21 to 71 years (median: 54 years). Sixty-one percent (15/23) of the patients and 74% (20/27) of the food handlers were female.

The annual age-specific incidence of O157 and non-O157 infections in Miyagi Prefecture during the study period is summarized in Table 1. In this region, the overall incidence of STEC infection was 1.6, with infants and small children having the highest incidence (13.5, P<0.001 vs. each other age group). Importantly, the incidence of non-O157 infections was significantly higher in infants and small children (11.3) than in the other age groups (P<0.001 vs. each other age group), while there was no significant difference in the incidence of O157 infections among the age groups.

Tab. 1. Annual age-specific incidence of Shiga toxin-producing Escherichia coli (STEC) infection in Miyagi Prefecture during the study period.
Annual age-specific incidence of Shiga toxin-producing <i>Escherichia coli</i> (STEC) infection in Miyagi Prefecture during the study period.

Virulence genes

Among a total of 76 virulence genes registered in VirulenceFinder, 44 genes (58%) were detected among the isolates and there was a median of 17 virulence genes per isolate (range: 1–26). Isolates from the patients harbored significantly more virulence genes than isolates from the food handlers (a median of 18 and 10 virulence genes per isolate, respectively, P<0.001), and O157 isolates had significantly more virulence genes than non-O157 isolates (a median of 19 and 16 virulence genes per isolate, respectively, P = 0.013). Eight different Stx subtypes (combinations) were detected among the isolates, with stx1a-only being most frequent (n = 27, 42%), followed by stx1a+stx2a (n = 12, 18%). The distribution of virulence genes among isolates from the patients or food handlers and among O157 or non-O157 isolates is shown in S1 Fig and S1 Table.

Isolates with major serotypes had significantly more virulence genes than isolates with minor serotypes (a median of 18 and 7 virulence genes per isolate, respectively, P<0.001). The Stx subtype stx1a was significantly more frequent among isolates with major serotypes, while stx2d and stx2e were detected significantly more often in isolates with minor serotypes. Among the 48 isolates with major serotypes, adhesion genes eae, tir, and espB were detected in 47 (98%), 46 (96%), and 45 (94%) isolates respectively, and secretion system genes espA, espJ, nleA, nleB, and nleC were detected in 46 (96%), 46 (96%), 41 (85%), 45 (94%), and 41 (85%) isolates respectively, whereas all isolates with minor serotypes were negative for all of these genes (all P<0.001) (Table 2).

Tab. 2. Distribution of putative virulence genes among Shiga toxin-producing Escherichia coli (STEC) isolates with major/minor serotypes and O157/non-O157 isolates from patients.
Distribution of putative virulence genes among Shiga toxin-producing <i>Escherichia coli</i> (STEC) isolates with major/minor serotypes and O157/non-O157 isolates from patients.

Among the isolates from patients, O157 and non-O157 isolates had a comparable number of virulence genes (a median of 17 virulence genes per isolate, respectively, P = 0.32). Stx gene stx1a, adhesion gene efa1, secretion system genes espF and cif, and fimbrial gene lpfA were significantly more frequent among non-O157 isolates from patients than among O157 isolates from patients (Table 2). In addition, stx1a, lpfA, and secretion system gene tccP were significantly more frequent in isolates from patients that were infants and small children than in isolates from patients of other age groups (S2 Table). The isolate from the 1 patient with HUS had stx2c-only, as well as adhesion genes eae, tir, and espB, and secretion system genes espA, espJ, nleA, nleB and nleC.

The additional search for saa using BLAST showed that only 5 out of 65 isolates (7%) possessed this gene. All of these isolates were non-O157 and from food handlers.

AMR genes

WGS analysis identified 20 acquired AMR genes in 18 STEC isolates (28% of all 65 STEC isolates) (S1 Fig). The β-lactamase gene (blaTEM-1B) was detected in 7 isolates (11%). There were 14 isolates (22%), 16 isolates (25%), 11 isolates (17%), 3 isolates (5%), and 2 isolates (3%) with at least one of the sulfamethoxazole/trimethoprim, aminoglycoside, tetracycline, macrolide, and phenicol resistance genes, respectively. The distribution of AMR genes was similar among isolates from the patients or food handlers and among O157 or non-O157 isolates. Aminoglycoside resistance genes were less frequent among isolates with major serotypes than isolates with minor serotypes (22/48 isolates with major serotypes versus 16/17 isolates with minor serotypes, P<0.001).

Phylogenetic analysis

Phylogenetic analysis was performed using 132,711 SNPs identified within the core genome of 71 STEC isolates (including the 6 reference strains) (Fig 2). The STEC isolates were divided into two clades, O157 and non-O157, except that the O145:H28 isolate clustered with the O157 isolates. Isolates with the same O serotype formed a cluster together, except for O103 and O8. In addition, the O103:H8 ST2836 isolates clustered with the O26:H11 isolates and were separated from the O103:H2 ST17 isolate. Within the O157:H7 cluster, isolates positive for stx1a+stx2a formed a subcluster. Isolates positive for microcin genes mcmA, mchB, mchC, and mchF were assigned to a subcluster within the O26:H11 cluster.

Maximum likelihood tree based on the core genome shared by Shiga toxin-producing <i>Escherichia coli</i> (STEC) isolates, including reference strains.
Fig. 2. Maximum likelihood tree based on the core genome shared by Shiga toxin-producing Escherichia coli (STEC) isolates, including reference strains.
Scale bar represents 8.0 nucleotide substitutions per site. A total of 132,711 SNPs were identified in the core genome. The average number of SNPs showing differences between each pair of STEC isolates was 33,603. Yellow shading = isolates with major serotypes; light green shading = isolates with minor serotypes. Closely related isolates (SNP differences <5) are highlighted with red lines behind them. aST: sequence type. bStx: Shiga toxin. cOUT: O-serotype untypable.

In pairwise comparisons, the median number of SNP differences between different core genomes was 423 within O157 (range, 0 to 584), compared to 22,054 (range, 0 to 54,528) for non-O157 genomes overall. Twenty isolates (6, 10, 2, and 2 isolates with O157:H7 ST11, O26:H11 ST21, O103:H8 ST2836, and O76:H19 ST675, respectively) were divided into 9 indistinguishable core genomes (<5 SNPs) (Fig 2). Among these 9 core genomes, 5 were from patients, 3 were from food handlers, and one was isolated from both a patient and a food handler. Two of the 4 O26:H11 strains, including one strain positive for stx1a+stx2a, were from patients under 5 years of age.

Discussion

To the best of our knowledge, this is the first genomic epidemiological study to investigate STEC isolates from patients and asymptomatic food handlers. Isolates with 5 non-O157 serotypes (O26:H11, O103:H2, O103:H8, O121:H19, and O145:H28), which had as many virulence genes as O157 isolates were prevalent among both patients and food handlers, whereas isolates with the remaining 12 serotypes were only found in food handlers and were negative for major virulence genes, eae, tir, espB, espA, espJ, nleA, nleB, and nleC. Non-O157 isolates were especially prevalent among children under 5 years of age. WGS analysis revealed clonal expansion of highly virulent STEC strains (e.g., O26:H11 strain with stx1a+stx2a) in our region (Miyagi Prefecture, Japan).

Although the overall isolation rate of non-O157 STEC strains was reported to be 30–40% in Japan [3], more than half of the STEC isolates were non-O157 strains in our region. Similar to the increment of non-O157 isolates revealed by this study, non-O157 infections have been increasingly reported worldwide [2, 21]. Notably, non-O157 infection was predominant among children under 5 years old in this study. Among the isolates from patients, adhesin gene efa1, secretion system genes espF and cif, and the gene lpfA encoding fimbriae, were significantly more frequent among non-O157 isolates than O157 isolates. lpfA was reported to be involved in prolonged shedding of STEC in young children [22]. In Japan, direct person-to-person contact is the suspected route of transmission for the majority of STEC infection outbreaks among children [23]. Prolonged shedding of STEC can facilitate its spread. Our findings suggested that these genes may be associated with a high frequency of non-O157 STEC infection among children.

The isolates with major serotypes (O157:H7, O26:H11, O103:H2, O103:H8, O121:H19, and O145:H28) harbored significantly more virulence genes than the isolates with minor serotypes. Apart from O103:H8, these major serotypes have been linked to epidemics and serious infections and have been frequently detected among clinical isolates worldwide [24]. Most of the isolates with major serotypes, including the isolate from a patient with HUS, possessed adhesion genes eae, tir, and espB, and secretion system genes espA, espJ, nleA, nleB and nleC, whereas the isolates with minor serotypes were negative for all of these genes. Studies have shown that the eae gene encoding intimin, an outer membrane protein involved in close attachment, is closely linked to the pathogenesis of STEC infection, along with other genes clustering on the bacterial chromosome (such as tir, espA, espB, and espJ) that form a pathogenicity island called the locus of enterocyte effacement [8, 25]. Other studies have shown that effectors outside this locus encoded by nleA, nleB, and nleC are required to form attaching and effacing lesions in the intestinal epithelium, which allow STEC to colonize the human gut [26]. Accordingly, these virulence factors may play a key role in the pathogenesis of STEC infections. The current STEC surveillance system for food handlers in Japan is only based on serotyping and detection of Stx [3]. However, we think that STEC surveillance should focus on the above-mentioned virulence genes, such as eae, tir, espB, espA, espJ, nleA, nleB and nleC.

O103:H8 ST2836 STEC with multiple virulence genes was newly detected in this study. O103:H8 ST2836 isolates formed a separate cluster from the known isolates of O103:H2 ST17 on the phylogenetic tree, suggesting that these two clusters of serogroup O103 had different origins. As previously reported, STEC are E. coli strains of different lineages that have acquired virulence genes independently at different time points [27], and STEC strains from the same O serogroups are polyphyletic since horizontal transfer of the O-antigen gene can occur among different E. coli strains [28]. These points raise the possibility that new serotypes of highly virulent STEC may emerge.

There have only been a limited number of epidemiological studies on AMR in STEC isolates [6]. The resistance genes with the highest prevalence among our STEC isolates were aminoglycoside resistance genes (e.g., aadA, aph(3’)-I, and str), followed by sulfamethoxazole/trimethoprim resistance genes (e.g., sul and dfrA). In Japan, sulfamethoxazole/trimethoprim and aminoglycosides are antibacterial agents commonly used in domestic animals [29], which are the main reservoir of STEC, and the prevalence of aminoglycoside resistance among STEC isolates from cows in Japan has increased during the past decade [30]. Antimicrobial therapy is generally not recommended for STEC infection due to the possible risk of HUS, but it may be beneficial for patients with persistent diarrhea or food handlers with long-term STEC carriage [31]. Transfer of mobile genetic elements was reported to facilitate the spread of AMR genes to other bacteria [6]. Accordingly, it is important to monitor AMR in STEC isolates and prevent misuse/overuse of antibiotics based on the One Health approach [32].

WGS-based phylogenic analysis revealed a variety of SNP variants among isolates from the same serogenotype or same ST clade, suggesting dissemination of diverse STEC strains throughout our region. The O157:H7 isolates with stx1a+stx2a formed a subcluster within the O157:H7 cluster, and the O26:H11 isolates positive for microcin genes formed a subcluster in the O26:H11 cluster. STEC isolates possessing stx1a+stx2a have been linked to outbreaks associated with a high frequency of HUS [33]. The presence of microcin genes indicates environmental plasticity of the isolates since microcin is a bactericidal antibiotic [34]. These results highlight the fact that diverse strains with differing levels of virulence can exist within the same STEC serogroup.

Our phylogenetic analysis also detected 9 clonal expansions of STEC strains suggesting circulation of these strains among patients and food handlers in our region. One of the strains was serogenotype O26:H11 ST21 strain harboring stx1a+stx2a, which differed from a newly emerging virulent O26:H11/H- ST29 STEC clade reported in Japan by Ishijima et al [35]. In general, the majority of STEC O26:H11 isolates are only positive for stx1a [36, 37], highly virulent stx2a-containing O26:H11 strains have been increasingly reported worldwide in recent years [36]. The spread of O26:H11 strains with stx2a could pose a threat in our region. WGS has been employed to investigate the molecular epidemiology of STEC [7], since it is a powerful tool for performing high-resolution molecular typing, population structure analysis, and detailed molecular characterization of microbes [38]. Further genome-based epidemiological studies are needed to provide a better understanding of STEC isolates for assistance in developing prevention and control strategies.

This study had several limitations. First, there were only a few of STEC strains from the same lineage or serotype, although we assessed all of the STEC isolates detected through public health surveillance in our region during the study period. Second, we could only obtain restricted epidemiological and clinical information. Third, while this in silico study was focused on putative virulence genes, the pathogenicity of STEC isolates needs to be clarified by in vitro and in vivo experimental studies.

In conclusion, we found that genetically diverse non-O157 isolates (O26:H11, O103:H2, O103:H8, O121:H19, and O145:H28) with as many important virulence genes as O157 isolates (including eae, tir, espB, espA, espJ, nleA, nleB and nleC) plus AMR genes (such as aminoglycoside and sulfamethoxazole/trimethoprim resistance genes) were prevalent among both patients and asymptomatic food handlers in Miyagi Prefecture, Japan. Our WGS analysis demonstrated the importance of monitoring the genomic characteristics of STEC isolates from asymptomatic food handlers in addition to symptomatic patients.

Supporting information

S1 Fig [black]
Characteristics and virulence/antimicrobial resistance (AMR) gene profiles of Shiga toxin-producing (STEC) isolates.

S1 Table [xlsx]
Distribution of putative virulence genes among Shiga toxin-producing (STEC) isolates from patients/food handlers and O157/non-O157 isolates.

S2 Table [xlsx]
Distribution of putative virulence genes among Shiga toxin-producing (STEC) isolates from patients of infants and small children/patients of different age groups.


Zdroje

1. Amezquita-Lopez BA, Soto-Beltran M, Lee BG, Yambao JC, Quinones B. Isolation, genotyping and antimicrobial resistance of Shiga toxin-producing Escherichia coli. J Microbiol Immunol Infect. 2018;51: 425–434. doi: 10.1016/j.jmii.2017.07.004 28778595

2. Valilis E, Ramsey A, Sidiq S, DuPont HL. Non-O157 Shiga toxin-producing Escherichia coli-A poorly appreciated enteric pathogen: Systematic review. Int J infect Dis. 2018;76: 82–87. doi: 10.1016/j.ijid.2018.09.002 30223088

3. Terajima J, Iyoda S, Ohnishi M, Watanabe H. Shiga Toxin (Verotoxin)-Producing Escherichia coli in Japan. Microbiol Spectr. 2014;2(5).

4. Harada T, Hirai Y, Itou T, Hayashida M, Seto K, Taguchi M, et al. Laboratory investigation of an Escherichia coli O157:H7 strain possessing a vtx2c gene with an IS1203 variant insertion sequence isolated from an asymptomatic food handler in Japan. Diagn Microbiol Infect Dis. 2013;77: 176–178. doi: 10.1016/j.diagmicrobio.2013.06.012 23891550

5. Scheutz F, Teel LD, Beutin L, Pierard D, Buvens G, Karch H, et al. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol. 2012;50: 2951–2963. doi: 10.1128/JCM.00860-12 22760050

6. Day M, Doumith M, Jenkins C, Dallman TJ, Hopkins KL, Elson R, et al. Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England, 2015. J Antimicrob Chemother. 2017;72: 145–152. doi: 10.1093/jac/dkw371 27678285

7. Haugum K, Johansen J, Gabrielsen C, Brandal LT, Bergh K, Ussery DW, et al. Comparative genomics to delineate pathogenic potential in non-O157 Shiga toxin-producing Escherichia coli (STEC) from patients with and without haemolytic uremic syndrome (HUS) in Norway. PLoS ONE. 2014;9(10):e111788. doi: 10.1371/journal.pone.0111788 25360710

8. Ferdous M, Friedrich AW, Grundmann H, de Boer RF, Croughs PD, Islam MA, et al. Molecular characterization and phylogeny of Shiga toxin-producing Escherichia coli isolates obtained from two Dutch regions using whole genome sequencing. Clin Microbiol Infect. 2016;22(7):642.e1–9.

9. World Health Organization. World health report. 50 Facts: Global health situation and trends 1955–2025. 2019. Available from: https://www.who.int/whr/1998/media_centre/50facts/en/

10. Nishijima S, Suda W, Oshima K, Kim SW, Hirose Y, Morita H, et al. The gut microbiome of healthy Japanese and its microbial and functional uniqueness. DNA Res. 2016;23: 125–133. doi: 10.1093/dnares/dsw002 26951067

11. Bolger AM, Lohse M, Usadel B. Trimmomatic: A flexible trimmer for Illumina Sequence Data. Bioinformatics. 2014;30: 2114–2120. doi: 10.1093/bioinformatics/btu170 24695404

12. Kajitani R, Toshimoto K, Noguchi H, Toyoda A, Ogura Y, Okuno M, et al. Efficient de novo assembly of highly heterozygous genomes from whole-genome shotgun short reads. Genome Res. 2014;24: 1384–1395. doi: 10.1101/gr.170720.113 24755901

13. Joensen KG, Tetzschner AM, Iguchi A, Aarestrup FM, Scheutz F. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol. 2015;53: 2410–2426. doi: 10.1128/JCM.00008-15 25972421

14. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol. 2012;50:1355–1361. doi: 10.1128/JCM.06094-11 22238442

15. Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, Nielsen EM, et al. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli. J Clin Microbiol. 2014;52: 1501–1510. doi: 10.1128/JCM.03617-13 24574290

16. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, et al. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012;67: 2640–2644. doi: 10.1093/jac/dks261 22782487

17. Treangen TJ, Ondov BD, Koren S, Phillippy AM. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol. 2014;15: 524. doi: 10.1186/s13059-014-0524-x 25410596

18. Dallman TJ, Byrne L, Ashton PM, Cowley LA, Perry NT, Adak G, et al. Whole-genome sequencing for national surveillance of Shiga toxin-producing Escherichia coli O157. Clin Infect Dis. 2015;61: 305–312. doi: 10.1093/cid/civ318 25888672

19. Stamatakis A. Using RAxML to infer phylogenies. Curr Protoc Bioinformatics. 2015;51: 6.14.1–14.

20. DebRoy C, Fratamico PM, Yan X, Baranzoni G, Liu Y, Needleman DS, et al. Comparison of O-antigen gene clusters of all O-serogroups of Escherichia coli and proposal for adopting a new nomenclature for O-typing. PLoS One, 2016;11: e0147434. doi: 10.1371/journal.pone.0147434 26824864

21. Byrne L, Vanstone GL, Perry NT, Launders N, Adak GK, Godbole G, et al. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009–2013. J Med Microbiol. 2014;63: 1181–1188. doi: 10.1099/jmm.0.075895-0 24928216

22. Matussek A, Jernberg C, Einemo IM, Monecke S, Ehricht R, Engelmann I, et al. Genetic makeup of Shiga toxin-producing Escherichia coli in relation to clinical symptoms and duration of shedding: a microarray analysis of isolates from Swedish children. Eur J Clin Microbiol Infect Dis. 2017;36: 1433–1441. doi: 10.1007/s10096-017-2950-7 28421309

23. Kanayama A, Yahata Y, Arima Y, Takahashi T, Saitoh T, Kanou K, et al. Enterohemorrhagic Escherichia coli outbreaks related to childcare facilities in Japan, 2010–2013. BMC Infect Dis. 2015;15: 539. doi: 10.1186/s12879-015-1259-3 26589805

24. Karmali MA, Mascarenhas M, Shen S, Ziebell K, Johnson S, Reid-Smith R, et al. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol. 2003;41: 4930–4940. doi: 10.1128/JCM.41.11.4930-4940.2003 14605120

25. McWilliams BD, Torres AG. Enterohemorrhagic Escherichia coli adhesins. Microbiol Spectr. 2014;2(3).

26. Cepeda-Molero M, Berger CN, Walsham ADS, Ellis SJ, Wemyss-Holden S, Schuller S, et al. Attaching and effacing (A/E) lesion formation by enteropathogenic E. coli on human intestinal mucosa is dependent on non-LEE effectors. PLoS Pathog. 2017;13(10):e1006706. doi: 10.1371/journal.ppat.1006706 29084270

27. Steyert SR, Sahl JW, Fraser CM, Teel LD, Scheutz F, Rasko DA. Comparative genomics and stx phage characterization of LEE-negative Shiga toxin-producing Escherichia coli. Front Cell Infect Microbiol. 2012;2: 133. doi: 10.3389/fcimb.2012.00133 23162798

28. Iguchi A, Shirai H, Seto K, Ooka T, Ogura Y, Hayashi T, et al. Wide distribution of O157-antigen biosynthesis gene clusters in Escherichia coli. PLoS ONE. 2011;6(8):e23250. doi: 10.1371/journal.pone.0023250 21876740

29. Hosoi Y, Asai T, Koike R, Tsuyuki M, Sugiura K. Sales of veterinary antimicrobial agents for therapeutic use in food-producing animal species in Japan between 2005 and 2010. Rev Sci Tech. 2014;33: 1007–1015. doi: 10.20506/rst.33.3.2337 25812223

30. Kobayashi H, Kanazaki M, Ogawa T, Iyoda S, Hara-Kudo Y. Changing prevalence of O-serogroups and antimicrobial susceptibility among STEC strains isolated from healthy dairy cows over a decade in Japan between 1998 and 2007. J Vet Med Sci. 2009;71: 363–366. doi: 10.1292/jvms.71.363 19346709

31. Agger M, Scheutz F, Villumsen S, Molbak K, Petersen AM. Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal. J Antimicrob Chemother. 2015;70: 2440–2446. doi: 10.1093/jac/dkv162 26093376

32. Rabinowitz PM, Kock R, Kachani M, Kunkel R, Thomas J, Gilbert J, et al. Toward proof of concept of a one health approach to disease prediction and control. Emerg Infect Dis. 2013;19(12).

33. Soborg B, Lassen SG, Muller L, Jensen T, Ethelberg S, Molbak K, et al. A verocytotoxin-producing E. coli outbreak with a surprisingly high risk of haemolytic uraemic syndrome, Denmark, September-October 2012. Euro Surveill. 2013;18(2).

34. Lavina M, Gaggero C, Moreno F. Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli. J Bacteriol. 1990;172: 6585–6588. doi: 10.1128/jb.172.11.6585-6588.1990 2228975

35. Ishijima N, Lee KI, Kuwahara T, Nakayama-Imaohji H, Yoneda S, Iguchi A, et al. Identification of a new virulent clade in enterohemorrhagic Escherichia coli O26:H11/H- sequence type 29. Sci Rep. 2017;7:43136. doi: 10.1038/srep43136 28230102

36. Bielaszewska M, Mellmann A, Bletz S, Zhang W, Kock R, Kossow A, et al. Enterohemorrhagic Escherichia coli O26:H11/H-: a new virulent clone emerges in Europe. Clin Infect Dis. 2013;56: 1373–1381. doi: 10.1093/cid/cit055 23378282

37. National Institute of Infectious Diseases. Enterohemorrhagic Escherichia coli (EHEC) infection, as of March 2019, Japan. Infect Agents Surveill Rep. 2019;40: 71–72.

38. Rusconi B, Sanjar F, Koenig SS, Mammel MK, Tarr PI, Eppinger M. Whole genome sequencing for genomics-guided investigations of Escherichia coli O157:H7 outbreaks. Front Microbiol. 2016;7:985. doi: 10.3389/fmicb.2016.00985 27446025


Článek vyšel v časopise

PLOS One


2019 Číslo 11
Nejčtenější tento týden
Nejčtenější v tomto čísle
Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Svět praktické medicíny 1/2024 (znalostní test z časopisu)
nový kurz

Koncepce osteologické péče pro gynekology a praktické lékaře
Autoři: MUDr. František Šenk

Sekvenční léčba schizofrenie
Autoři: MUDr. Jana Hořínková

Hypertenze a hypercholesterolémie – synergický efekt léčby
Autoři: prof. MUDr. Hana Rosolová, DrSc.

Význam metforminu pro „udržitelnou“ terapii diabetu
Autoři: prof. MUDr. Milan Kvapil, CSc., MBA

Všechny kurzy
Kurzy Podcasty Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Zadejte e-mailovou adresu, se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se

#ADS_BOTTOM_SCRIPTS#